Perceptions and lived experiences with abemaciclib and endocrine therapy for early breast cancer: a rapid communication
Perceptions and lived experiences with abemaciclib and endocrine therapy for early breast cancer: a rapid communication is a paper indexed in ScholarIQ from OpenAlex.
How many citations does Perceptions and lived experiences with abemaciclib and endocrine therapy for early breast cancer: a rapid communication have?
Perceptions and lived experiences with abemaciclib and endocrine therapy for early breast cancer: a rapid communication has 0 citations in the OpenAlex counts ScholarIQ stores.
When was Perceptions and lived experiences with abemaciclib and endocrine therapy for early breast cancer: a rapid communication published?
Perceptions and lived experiences with abemaciclib and endocrine therapy for early breast cancer: a rapid communication has 2026 year in the ScholarIQ index.
What is the open-access status of Perceptions and lived experiences with abemaciclib and endocrine therapy for early breast cancer: a rapid communication?
Perceptions and lived experiences with abemaciclib and endocrine therapy for early breast cancer: a rapid communication has green oa status in the ScholarIQ index.
What is the DOI of Perceptions and lived experiences with abemaciclib and endocrine therapy for early breast cancer: a rapid communication?
The DOI for Perceptions and lived experiences with abemaciclib and endocrine therapy for early breast cancer: a rapid communication is on the source record.
What is the PMID of Perceptions and lived experiences with abemaciclib and endocrine therapy for early breast cancer: a rapid communication?
The PMID for Perceptions and lived experiences with abemaciclib and endocrine therapy for early breast cancer: a rapid communication is on the source record.
What is the OpenAlex record for Perceptions and lived experiences with abemaciclib and endocrine therapy for early breast cancer: a rapid communication?
The OpenAlex for Perceptions and lived experiences with abemaciclib and endocrine therapy for early breast cancer: a rapid communication is on the source record.